Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

50.51
Delayed Data
As of Aug 04
 +0.01 / +0.02%
Today’s Change
39.28
Today|||52-Week Range
51.74
+12.19%
Year-to-Date

Today’s Trading

Previous close50.50
Today’s open50.75
Day’s range50.29 - 50.81
Volume3,487,660
Average volume (3 months)4,953,403
Market cap$75.2B
Dividend yield1.90%
Data as of 08/04/2015

Growth & Valuation

Earnings growth (last year)-8.61%
Earnings growth (this year)-5.00%
Earnings growth (next 5 years)+9.95%
Revenue growth (last year)-7.33%
P/E ratio37.9
Price/Sales3.40
Price/Book3.54

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.40+1.18%
VRXValeant Pharmaceutic...+2.77+1.08%
LLYEli Lilly and Co-0.09-0.11%
SHPGShire-14.48-5.40%
Data as of 08/04/2015

Financials

Next reporting dateOctober 21, 2015
EPS forecast (this quarter)$0.54
Annual revenue (last year)$20.2B
Annual profit (last year)$2.3B
Net profit margin8.50%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
VP-Investor Relations
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts